PAREXEL® Access eHub:

Value Through Evidence

Back to Content Hub

Case Study: Expanded access program

When a client wanted to give eligible patients early access to a promising product, PAREXEL used its global infrastructure and expertise to administer, manage and monitor drug access across 3,000 sites in over 75 countries.

Case Study: Multiple Late Phase Challenges Require Smarter Late Phase Solutions

Share this: